Navigation Links
Marinus Pharmaceuticals Raises $20 Million in Series B Financing
Date:4/10/2009

antiepileptic drug and will address significant unmet medical needs for patients with epilepsy. We are very excited about the future prospects for Marinus."

About Ganaxolone

Ganaxolone is a synthetic neurosteroid and derivative of the naturally occurring neuromodulator, allopregnanolone. It is being investigated as a first in class treatment for epilepsy. Ganaxolone has been administered to more than 950 healthy adult volunteers and patients in more than 35 Phase 1 and Phase 2 studies. Early epilepsy studies involved more than 100 patients and generated data supportive of the efficacy and safety of ganaxolone in the treatment of both children and adults suffering from refractory forms of epilepsy (patients who continue to have seizures despite taking multiple anticonvulsant drugs).

Marinus has successfully developed several proprietary formulations of ganaxolone.

About Marinus Pharmaceuticals

Marinus Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders. Marinus Pharmaceuticals is located in Branford, Conn. Its investors include Domain Associates, Canaan Partners, Sofinnova Ventures and Foundation Medical Partners. For additional information, please visit the Company's Web site at http://www.marinuspharma.com/XQUOT;" target="_new">www.marinuspharma.com.

About Domain Associates

Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on life sciences. With $2 billion of capital under management, Domain is headquartered in Princeton, NJ with a second office in San Diego, CA. Domain's three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices
'/>"/>

SOURCE Marinus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
2. OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
3. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
4. Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS
5. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
6. VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
7. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
8. Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments
9. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
10. NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
11. Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Today the National Institutes of ... for the Brain Research through Advancing Innovative Neurotechnologies ... and revolutionize new methods of understanding the complexities ... This first round of grants totaling $46 million ... to more than 100 investigators in 15 states ...
(Date:10/1/2014)... 01, 2014 Slone Partners , ... Healthcare IT, and Laboratory Testing industries, reported a 120% ... the director level and above from July 2013 to ... on top of rapid breakthroughs in diagnostics, reimbursement has ... companies have been forced to fold, consolidate, or carry ...
(Date:10/1/2014)... 1, 2014 Industry leaders ... to engage around the theme, ,Commercial Opportunities in the ...   Elsevier , a world-leading provider ... will host a gathering of some of the industry,s ... impacting healthcare today and in the future. The ...
(Date:9/30/2014)... Mass. Using a bio-mimicking analog of one ... grass, an international research team led by Alejandro ... taken a major step in developing long-sought polymer ... electricity for use in electronic devices. , ... Amherst and others at Stanford University and Dresden ...
Breaking Biology Technology:NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 2NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 3Slone Partners Meets Growing Demand as Industry Focuses on Reimbursement & Regulation 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3Blades of grass inspire advance in organic solar cells 2Blades of grass inspire advance in organic solar cells 3
... gather a burgeoning number of stem cell researchers into ... of Wisconsin-Madison has established the new Wisconsin Stem Cell ... UW-Madison Graduate School, the new initiative is intended to ... develop new resources and opportunities for as many as ...
... announced today that The Valley Hospital , ... in Ridgewood, N.J., has successfully implemented API's Payrollmation time ... ,Payrollmation automates time and attendance data collection and ... will improve employee morale and help the organization to ...
... University of Wisconsin-Madison students will compete for $22,000 ... G. Steve Burrill Technology Business Plan Competition . ... and various other disciplines, will pitch their plans for ... of the competition. , ,Within the UW System, this ...
Cached Biology Technology:UW Madison launches new stem cell research program 2Valley Hospital implements API's solution for 3,500 employees 2Students compete for $22,000 in Tech Business Plan Competition 2Students compete for $22,000 in Tech Business Plan Competition 3
(Date:9/30/2014)... aquatic environment on Earth, but when the climate changes ... the limit. The amount of time needed to adjust ... species cope in the future, reveals a new study ... the scientific journal Proceedings of the Royal Society ... increasing levels of greenhouse gases in the atmosphere. The ...
(Date:9/30/2014)... in Munich report that a new class of ... chemotherapeutic drugs. They have also pinpointed the relevant ... anti-tumor agents. , Researchers led by LMU,s ... the Technische Universitt Mnchen have identified a class ... in the fight against malignant tumors. The compound ...
(Date:9/30/2014)... , Sept. 30, 2014  Spectra Automation, ... for the biotech and power generation industries, ... RECONN Bioprocess Manager, an easy-to-use and cost-effective ... towards bioprocess development laboratories. ... bioreactor and analyzer systems. Accessing and consolidating ...
Breaking Biology News(10 mins):Shape up quickly -- applies to fish, too! 2Cancer therapy: Driving cancer cells to suicide 2Spectra Automation Introduces RECONN Bioprocess Manager 2
... the Howard Hughes Medical Institute have succeeded in mapping ... wide range of odors, including vanilla, skunk, fish, urine, ... ?patterns of neural activity represents a significant step in ... receptors in the nose into odor perception in the ...
... What does it take to fathom a proverb ?catch the ... tree"? , According to research led by V. S. Ramachandran, ... University of California, San Diego, a region of the brain ... responsible for the human ability to understand metaphor. , Ramachandran ...
... three months after deciding to create an electronic ... registry and results database using an independent host, ... can be accessed by anyone, anywhere, with no ... patients and healthcare providers ready access to information ...
Cached Biology News:Decoding the logic of olfaction 2Decoding the logic of olfaction 3Decoding the logic of olfaction 4Grasping metaphors: UC San Diego research ties brain area to figures of speech 2Roche clinical trial registry and results database launched 2Roche clinical trial registry and results database launched 3